181 related articles for article (PubMed ID: 26637749)
1. The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia.
DeAngelo DJ
Hematology Am Soc Hematol Educ Program; 2015; 2015():400-5. PubMed ID: 26637749
[TBL] [Abstract][Full Text] [Related]
2. Current status of antibody therapy in ALL.
Ai J; Advani A
Br J Haematol; 2015 Feb; 168(4):471-80. PubMed ID: 25382151
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
Hoelzer D
Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract][Full Text] [Related]
5. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
Farhadfar N; Litzow MR
Leuk Res; 2016 Oct; 49():13-21. PubMed ID: 27521873
[TBL] [Abstract][Full Text] [Related]
6. New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors.
Advani AS
Hematology Am Soc Hematol Educ Program; 2013; 2013():131-7. PubMed ID: 24319174
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of relapsed or refractory acute lymphoblastic leukemia].
Imai K
Rinsho Ketsueki; 2017; 58(10):1995-2003. PubMed ID: 28978841
[TBL] [Abstract][Full Text] [Related]
8. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
Kebriaei P; Poon ML
Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
[TBL] [Abstract][Full Text] [Related]
9. Novel Therapies in Acute Lymphoblastic Leukemia.
Phelan KW; Advani AS
Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
[TBL] [Abstract][Full Text] [Related]
10. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.
O'Dwyer KM; Liesveld JL
Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691
[TBL] [Abstract][Full Text] [Related]
11. Antibody therapy for acute lymphoblastic leukemia.
Portell CA; Advani AS
Curr Hematol Malig Rep; 2012 Jun; 7(2):153-9. PubMed ID: 22422550
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
Hochberg J; El-Mallawany NK; Cairo MS
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
[TBL] [Abstract][Full Text] [Related]
13. Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia.
Advani A
Best Pract Res Clin Haematol; 2015; 28(2-3):116-23. PubMed ID: 26590768
[TBL] [Abstract][Full Text] [Related]
14. How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?
Gökbuget N
Best Pract Res Clin Haematol; 2017 Sep; 30(3):261-274. PubMed ID: 29050699
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in acute lymphoblastic leukemia.
Jabbour E; O'Brien S; Ravandi F; Kantarjian H
Blood; 2015 Jun; 125(26):4010-6. PubMed ID: 25999456
[TBL] [Abstract][Full Text] [Related]
16. Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study.
Gorin NC; Isnard F; Garderet L; Ikhlef S; Corm S; Quesnel B; Legrand O; Cachanado M; Rousseau A; Laporte JP
Eur J Haematol; 2013 Oct; 91(4):315-21. PubMed ID: 23738686
[TBL] [Abstract][Full Text] [Related]
17. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
Gökbuget N; Hoelzer D
Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
[TBL] [Abstract][Full Text] [Related]
18. The future role of monoclonal antibody therapy in childhood acute leukaemias.
Barth M; Raetz E; Cairo MS
Br J Haematol; 2012 Oct; 159(1):3-17. PubMed ID: 22881237
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.
Dias A; Kenderian SJ; Westin GF; Litzow MR
Curr Hematol Malig Rep; 2016 Aug; 11(4):253-64. PubMed ID: 27101015
[TBL] [Abstract][Full Text] [Related]
20. Salvage therapy for refractory or relapsed acute lymphocytic leukemia.
Garcia-Manero G; Thomas DA
Hematol Oncol Clin North Am; 2001 Feb; 15(1):163-205. PubMed ID: 11253606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]